APDQX
Price
$15.93
Change
+$0.03 (+0.19%)
Updated
Sep 5 closing price
Net Assets
912.25M
JVMSX
Price
$29.93
Change
+$0.44 (+1.49%)
Updated
Sep 4 closing price
Net Assets
24.32B
Interact to see
Advertisement

APDQX vs JVMSX

Header iconAPDQX vs JVMSX Comparison
Open Charts APDQX vs JVMSXBanner chart's image
Artisan Mid Cap Value Advisor
Price$15.93
Change+$0.03 (+0.19%)
VolumeN/A
Net Assets912.25M
JHancock Disciplined Value Mid Cap R2
Price$29.93
Change+$0.44 (+1.49%)
VolumeN/A
Net Assets24.32B
APDQX vs JVMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
APDQX vs. JVMSX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APDQX is a Buy and JVMSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 24.3B vs. APDQX (912M). APDQX pays higher dividends than JVMSX: APDQX (0.59) vs JVMSX (0.40). APDQX was incepted earlier than JVMSX: APDQX (10 years) vs JVMSX (14 years). JVMSX (1.25) is less costly to investors than APDQX (1.06). JVMSX is a more actively managed with annual turnover of: 49.00 vs. APDQX (23.41). JVMSX has a lower initial minimum investment than APDQX: JVMSX (0) vs APDQX (250000). JVMSX annual gain was more profitable for investors over the last year : 2.46 vs. APDQX (-1.40). JVMSX return over 5 years is better than : 52.77 vs. APDQX (-1.57).
APDQXJVMSXAPDQX / JVMSX
Total Expense Ratio1.061.2485%
Annual Report Gross Expense Ratio1.061.2585%
Fund Existence10 years14 years-
Gain YTD2.90711.71225%
Front LoadN/AN/A-
Min. Initial Investment2500000-
Min. Initial Investment IRAN/AN/A-
Net Assets912M24.3B4%
Annual Yield % from dividends0.590.40147%
Returns for 1 year-1.402.46-57%
Returns for 3 years-12.2123.90-51%
Returns for 5 years-1.5752.77-3%
Returns for 10 years-26.8654.59-49%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARWR29.081.08
+3.84%
Arrowhead Pharmaceuticals
LSTA2.170.06
+2.84%
Lisata Therapeutics
AARD8.600.11
+1.30%
Aardvark Therapeutics Inc
MLM622.643.67
+0.59%
Martin Marietta Materials
CFFN6.49-0.06
-0.92%
Capitol Federal Financial